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Background: No population representative data on characteristics, treatment, and outcome
were available in acute coronary syndrome (ACS) patients.
Methods: The clinical characteristics, treatment, and in-hospital outcome of 5180 ACS
patients registered in multicenter ACS Registry across 33 hospitals in the state since January
2012 to December 2014 are reported. ACS was diagnosed using standard criteria.
Result: 70.8% were men; mean age was 60.9  12.1. NSTEMI was more frequent than STEMI
(54.5% vs. 45.5%). 83.3% of the ACS population were from rural area. Pre-hospital delay was
long, with a median of 780 min. 35.6% of STEMI patients received thrombolytic therapy.
Evidence-based treatment was prescribed in more than 80% of ACS patients, and the
treatment was similar in men and women across all types of health care centers. In-hospital
mortality was 7.6%, and was more frequent in STEMI than in NSTEMI (10.8% vs. 5.0%,
p < 0.001).
Interpretation: Pre-hospital delay was long, and use of reperfusion therapy was signiﬁcantly
lower. The in-hospital death rates are higher.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
Available online at www.sciencedirect.com
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Coronary artery disease (CAD) is a leading cause of morbidity
and mortality in developed and developing countries.1,2
Acute coronary syndrome (ACS) is a commonest mode of
presentation among patients of CAD and carrying high rate
of morbidity and mortality.3 The incidence and outcomes of* Corresponding author.
E-mail address: negiprakash59@gmail.com (P.C. Negi).
http://dx.doi.org/10.1016/j.ihj.2015.07.027
0019-4832/# 2015 Cardiological Society of India. Published by ElsevieACS depend upon population exposure to risk factors, access
to quality health care services, and health seeking behavior
of the community.3–10 These, in turn, are inﬂuenced by
socioeconomic status, access to health information, geo-
graphical characteristics, and cultural practices. Thus, the
characteristics, the treatment, and outcomes are likely to
vary in different parts of the country and between the
countries.3–11 The CREATE registry data are based on datar B.V. All rights reserved.
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which are mostly tertiary care centers catering to urban
population.12 80% of the population in India live in rural area.
The characteristics of rural and urban ACS populations are
not reported in any of the ACS registries from India. The
Kerala ACS Registry, one of the largest state based registries
of India, has reported the characteristics, treatment, and
outcomes that are different from CREATE registry.13 The hill
state of Himachal Pradesh (HP) has better literacy rate14 and
health indicators15 than national average. The health care
services in HP are delivered primarily by the health care
centers in the government sector. There are only two
teaching institutions in the state, and IGMC Shimla is the
only tertiary care center with facilities for coronary angio-
plasty and CABG. The ACS patients are admitted and treated
by secondary care hospitals; district hospitals, civil hospitalsFig. 1 – District wise distribution of diffelocated at district head quarters, and at some block level,
respectively. In some districts, there are private hospitals
with indoor facilities, where patients of ACS are admitted
and treated. The health care access to rural ACS population is
limited by the long traveling time (Fig. 1). There are no
population representative data available on patient's char-
acteristics, treatment practices, and outcomes.
Thus, the multicentric ACS Registry was initiated in
March 2012 through networking of two teaching hospitals
in the state, all physician-manned hospitals in the govern-
ment sector, and volunteered hospitals in the private sector
to capture the data in predesigned format. This actual
preparatory work for establishing HP ACS Registry was
started since May 2011 that involved training and meeting
with physicians, designing and development of web-based
e-recording format.rent levels of ACS registry centers.
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2.1. Ethical approval
The registry protocol was approved by the institutional review
board of IGMC Shimla, and data were collected from the
eligible patients after obtaining their informed consent.
2.2. Selection of registry centers
All physician-manned centers in non-teaching hospital treat-
ing patients of ACS in the state of HP in government sectors
were listed and were included in the registry. All new centers
with physicians posted after start of registry were tracked and
were also included subsequently. The district hospital of Una
did not participate actively and were excluded. One tribal
district hospital of Lahaul and Spiti, which was without the
physician, was not included, as ACS patients were not treated
and admitted. Thus, the registry covered 10 out of 12 districts.
The registry also included both teaching hospitals, IGMC
Shimla with catheterization facilities, and RPGMC hospital
Tanda, which was without catheterization services. The
hospitals in private sectors treating patients of ACS were also
enlisted, and request was sent to these individual centers.
Those volunteered to participate in the registry were linked to
this multicenter HP ACS Registry. Out of 12 hospitals in private
sector treating patients of ACS, only 7 volunteered to
participate. Thus, a total of 33 registry centers, two teaching
hospitals, 24 secondary care hospitals in government sector,
and 7 private hospitals formed the part of multicentric HP ACS
Registry. These registry centers are covering more than 90% of
the HP population both rural and urban equally. The non-
physician-manned primary care hospitals do not treat and
admit these patients and are referred to these secondary level
hospitals in govt. sector. The teaching hospital IGMC, having
catheterization facility, functioned as the coordinating and
central registry center.
2.3. Diagnosis of ACS
Patients are diagnosed as ACS if presenting with acute chest
pain suggestive of ACS within preceding one week, associated
with any one of the following:
 ECG changes of ST segment deviation or T wave inversion or
Q waves in two or more contiguous leads
 Elevated markers of myocardial injury
 History of established CAD in past
2.4. STEMI
The patient is diagnosed when chest pain suggestive of ACS is
associated with ST segment elevation with and without ST
segment depression in two or more contiguous leads.
2.5. NSTEMI
The patient is diagnosed when chest pain suggestive of ACS is
associated with ST segment depression and or T waveinversion, Q waves in two or more contiguous leads associated
with elevated levels of markers of myocardial injury.
2.6. Unstable angina
The unstable angina was diagnosed in patients presenting
with chest pain suggestive of ACS without ECG and without
elevated level of myocardial injury but with past history of
documented CAD.
2.7. Case ascertainment
The case ascertainment in each registry center is done by the
local treating physician, and data from case record are entered
by the trained data entry operator of the respective center in
consultation with treating physician in the pre-structured
recording format. Thus, the diagnosis of ACS and type of ACS,
STEMI, or NSTEMI (including unstable angina) was based on
clinical documentation by treating physician, and no core lab
was used. The data are uploaded in the e-recording format in
the HP ACS web site after discharge or death.
2.8. Data collection
Data related to demographics, education, status of urban/rural
background, mode of transportation, pre-hospital delay, CV
risk factors, hemodynamic status, ACS types, treatments, and
in-hospital outcomes were recorded.
2.9. Quality control
Internal quality control is addressed by training of all partici-
pating physician and data entry operators employed by the state
health services for reporting other national program-related
health data. The quality of data and any missing data were
monitored on a daily basis at coordinating center by the data
manager, and any discrepancy in data entered are immediately
communicated to the respective registry center and is corrected
and settled. The external quality control was monitored by
periodic site visit by the ﬁeld research assistant and the data
entered are crosschecked from the source document.
The external quality control is monitored by periodic visit
by the project ﬁeld research assistant at each site to validate
the data entered from the source document and case ﬁle.
2.10. Statistical analysis
Data are reported as absolute frequency and relative frequency
for categorical variables and mean  SD for continuous vari-
ables. The signiﬁcance of differences in the distribution of
categorical variables among STEMI and NSTEMI population,
urban and rural population, men and women were analyzed
using x2-test for normal distribution and Mann–Whitney test for
skewed distribution of the characteristics. The difference in
distribution of continuous variables was compared using
unpaired t-test for normally distributed variable and Mann–
Whitney test for skewed distribution. Multi-variable logistic
modeling of clinical characteristics was done to estimate the
independent predictors of in-hospital mortality. Since pre-
hospital delay variable had skewed distribution, thus was log
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tal delay had normal distribution. Two-tailed signiﬁcance at
<0.05 was taken as statistically signiﬁcant. Statistical analysis
was done using statistical software STA version 13.
3. Results
3.1. Sociodemographic characteristics
Detailed description of sociodemographic characteristics is
given in Tables 1, 3 and 5. In brief, the mean age of the ACS
population was 60.9  12.1. STEMI ACS population was
younger than NSTEMI (59.9  12.1 vs. 61.8  12.0, p < 0.01).
The rural and women ACS populations were older than urban
and men ACS populations. NSTEMI was more common than
STEMI (54.5% vs. 45.5%, p < 0.01). ACS was more frequent in
men than in women (70.8% vs. 29.2%). NSTEMI was relatively
more common in women, while STEMI was more common in
men. The level of education was not different among STEMI
and NSTEMI groups. Proportion of ACS population (both STEMI
and NSTEMI) from rural background was signiﬁcantly higher
than from urban background (83.3% vs.16.7%). The ACS
population with STEMI were more frequently admitted in
tertiary care centers, while NSTEMI were admitted in second-
ary care hospitals.Table 1 – Sociodemographic characteristics, pre-hospital delay
distribution of ACS population.
Characteristics Overall gro
n = 5807
Demographic characteristics
Age strata 60.94  12.1
<40 years 260 (4.5%) 
41–50 years 1018 (17.5%
51–60 years 1679 (28.9%
61–70 years 1655 (28.5%
>71 years 1195 (20.6%
Gender (men) 4112 (70.8%
Education (median inter quartile range) 5977 
8.0 (0.0–10.0
Urban 971 (16.7%)
Rural 4836 (83.3%
Pre-hospital delay (median, inter quartile range) minutes 780 (242–23
Proportion reaching hospital within 6 h 1915 (33.0%
Proportion reaching within 12 h 858 (14.8%)
Reasons for delayed reporting
Ignorant of symptoms of ACS 1617 (33%) 
Consulting local practitioners/PHC 1426 (43.1%
Mode of transportation 
108 ambulance 862 (15.4%)
Private vehicle 2371 (42.3%
Taxi 1395 (24.9%
Public transport 450 (8.0%) 
Ambulance 382 (6.8%) 
Any other 149 (2.7%) 
Teaching hospitals with catheterization facilities 1701 (29.3%
RPGMC 1158 (19.9%
Non-teaching hospital (govt. sector) 2424 (41.7%
Non-teaching hospital (private hospital) 524 (9.0%) 3.2. Pre-hospital delay and mode of transportation
Median pre-hospital delay was 780 min and was similar in
both STEMI and NSTEMI. Only 33% reached within 6 h. The
characteristics of the ACS population reporting late in the
hospitals were women, patients from rural background, and
those reporting tertiary care centers and private hospitals. The
reasons for late reporting were ignorant about the symptoms
of ACS, intervened by primary care physicians, and long
traveling time. A personal vehicle was the commonest mode of
transportation, ‘‘108’’ national free ambulance service was
used only by 15.4%. Public transportation and ‘‘108’’ national
ambulance service were more frequently used by rural than
urban ACS population (Tables 1 and 3–5).
3.3. CV risk factors
The detailed description of risk factors treatment and outcome
is described in Tables 2–5. In brief, self-reported hypertension
and diabetes were recorded in 43.4% and 17.7%, respectively.
Diabetes, hypertension, and obesity were more frequently
associated with NSTEMI, women and urban ACS population,
while tobacco consumption was signiﬁcantly high in STEMI
than in NSTEMI. Tobacco consumption was reported in 63.4%
and was mostly in men than in women (80.6% vs. 21.5%).
Overweight and obesity were reported in 27.6% and 7.8%,, mode of transportation and types of hospital wise
up STEMI
n = 2641 (45.5%)
NSTEMI/Unstable angina
n = 3166 (54.5%)
p value
0 59.89  12.10 61.82  12.02 0.001
140 (5.3%) 120 (3.8%) 0.001
) 498 (18.9%) 520 (16.4%)
) 793 (30%) 886 (28.0%)
) 740 (28%) 915 (28.9%)
) 470 (17.8%) 725 (22.9%)
) 2043 (77.4%) 2069 (65.4%) 0.001
2636 3163 0.2
) 8.0 (0.0–10.0) 8.0 (0.0–20.0)
 464 (17.6%) 507 (16.0%) 0.1
) 2177 (82.4%) 2659 (84.0%)
58) 780.0 (258–2298) 780.0 (240–2410) 0.45
) 844 (32.0%) 1071 (33.8%) 0.13
 412 (15.6%) 446 (14.1%) 0.81
722 (31.4%) 895 (34.3%) 0.03
) 752 (47.6%) 674 (39.0%)
0.001
 371 (14.4%) 491 (16.1%)
) 1094 (42.6%) 1277 (42.0%)
) 635 (24.7%) 760 (25.0%)
190 (7.4%) 260 (8.5%)
216 (8.4%) 166 (5.5%)
62 (2.4%) 87 (2.9%)
) 882 (33.4%) 819 (25.9%) 0.001
(trends)
) 487 (18.4%) 671 (21.2%)
) 1025 (38.8%) 1399 (44.2%)
247 (9.4%) 277 (8.7%)
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and in urban ACS population. The distribution of CV risk
factors among ACS population reporting in different level of
hospitals was signiﬁcantly different.
3.4. Hemodynamic status
The hemodynamic instability state characterized by presence
of hypotension, tachycardia, Killip Class 111/1V and cardio-
genic shock was signiﬁcantly more common in STEMI than in
NSTEMI and in women ACS population (Tables 2–5). Hypoten-
sion and Killip Class 111/1V and cardiogenic shock were
reported in 11.7%, 11%, and 10.2%, respectively, and were more
often observed among rural ACS population and those
reporting teaching hospitals.
3.5. Electrocardiographic abnormalities
Fifty patients (0.9%) had VT/V.Fib., and was signiﬁcantly more
frequent among STEMI than in NSTEMI patients (1.4% vs. 0.6%,
p < 0.01). 4.7% had CHB and was signiﬁcantly higher among
STEMI than in NSTEMI patients (6.0% vs. 3.5%, p < 0.001) and 5
(0.1%) were in atrial ﬁbrillation (Table 2).Table 2 – CV risk factors, characteristics, treatment received, a
Characteristics Overall ACS group ST
CV risk factors
Self-reported hypertension 2510 (43.4%) 986
Self-reported diabetes 1022 (17.7%) 426
Tobacco smokers (yes) % 3658 (62.9%) 183
Sedentary (yes) % 1716 (29.7%) 746
BMI status 4953 (24.0  4.2) 223
BMI < 19.9 960 (18.4%) 487
BMI 20–24.9 2411 (46.2%) 113
BMI 25–29.9 1443 (27.6%) 596
>30 408 (7.8%) 140
Past H/O MI 420 (7.2%) 111
Past H/O CABG 52 (0.9%) 7 (0
Past H/O PCI 86 (1.5%) 16 (
Clinical characteristics
Tachycardia 985 (21.2%) 482
Hypotension 577 (11.7%) 383
Killip Class 111/1V 639 (11.0%) 353
A Fib 5 (0.1%) 3 (0
VT/VF 50 (0.9%) 30 (
CHB 246 (4.7%) 145
Stress hyperglycemia (FBS > 126) 1253 (46.3%) 524
Trop T positive 2309 (40.3%) 113
Treatment
ASA 5796 (100%) 263
Clopidogrel 5796 (100%) 263
Statin 5650 (97.3%) 257
B Blocker 4706 (81.1%) 201
ACE inhibitor/ARB 4716 (82.5%) 203
Thrombolytic therapy 948 (16.3%) 939
PCI 37 (0.6%) 25 (
Outcome
Death 442 (7.6%) (6.9–8.3%) 284
Bleeding 55 (1.0%) 33 (
Post-MI angina 125 (2.4%) 68 (
Cardiogenic shock 455 (10.2%) 2803.6. Treatment at and during hospitalization
Antiplatelets therapy, both ASA and Clopidogrel, was pre-
scribed in all patients both in STEMI and NSTEMI. 82.5%
received ACE inhibitors/ARBs and their use was similar in men
and women and urban and rural ACS population. Use of ACE
inhibitors/ARB was signiﬁcantly lower in STEMI than in
NSTEMI both in men and women and ACS population
admitted in private hospitals than in govt. hospitals at
secondary and tertiary care hospitals. Statins were prescribed
in 97.3% of ACS patients and was not different in men and
women and were prescribed equally among STEMI and
NSTEMI patients as well as in rural and urban ACS population.
However, Statins were prescribed less frequently in private
hospitals than in government hospitals. 81.1% received B
Blockers. STEMI ACS population received B Blockers less often
than NSTEMI patients 76.4% vs. 85.0%, respectively. ( p < 0.001).
Patients admitted in tertiary care center received B Blockers
less frequently than those admitted in secondary level
hospitals both in govt. and private sectors. Overall thrombo-
lytic therapy was used only in 35.6% of STEMI population. Use
of thrombolytic therapy was least in STEMI patients admitted
in tertiary care hospitals (32.5%), and was highest in STEMInd outcome in STEMI and NSTEMI ACS population.
EMI Group NSTEMI/Unstable angina Group p value
 (37.1%) 1524 (48.4%) 0.001
 (16.1%) 596 (19.0%) 0.01
4 (69.7%) 1823 (58.1%) 0.0001
 (28.3%) 970 (30.9%) 0.03
0 (23.6  4.1) 2720 (24.4  4.2) 0.001
 (20.7%) 473 (16.5%) 0.0001
0 (48.0%) 1281 (44.6%)
 (25.3%) 847 (29.5%)
 (5.9%) 268 (9.3%)
 (4.2%) 309 (9.8%) 0.01
.3%) 45 (1.4%) 0.01
0.6%) 70 (2.2%) 0.1
 (21.8%) 503 (20.7%) 0.02
 (16.1%) 245 (9.4%) 0.001
 (13.4%) 286 (9.0%) 0.001
.1%) 2 (0.1%) 0.5
1.4%) 20 (0.6%) 0.04
 (6.0%) 101 (3.5%) 0.0001
 (44.1%) 729 (48.1%) 0.04
3 (43.0%) 1176 (37.8%)
4 (100%) 3162 (100%)
4 (100%) 3162 (100%)
9 (97.7%) 3071 (97.1%) 0.5
7 (76.4%) 2689 (85.0%) 0.001
5 (78.5%) 2681 (86.0%) 0.01
 (35.6%) 9 (0.3%)
0.9%) 12 (0.4%) 0.01
 (10.8%) 158 (5.0%) 0.0001
1.4%) 22 (0.8% 0.07
2.8%) 57 (2.0%) 0.054
 (13.0%) 175 (7.6%) 0.001
Table 3 – Demographics, clinical characteristics, treatment, and outcomes of urban and rural ACS population.
Characteristics Overall Urban Rural p value
Age (mean  SD) 60.9  12.1 58.6  12.2 61.4  12.0 0.001
Age groups 0.0001
<40 years 260 (4.5%) 69 (7.1%) 191 (3.9%)
41–50 years 1018 (17.5%) 202 (20.8%) 1816 (16.9%)
51–60 years 1679 (28.9%) 299 (30.8%) 1380 (28.5%)
61–70 years 1655 (28.5%) 234 (24.6%) 1421 (29.4%)
>71 years 1195 (20.6%) 167 (17.2%) 1028 (21.3%)
Gender 0.001
Men 4112 (70.8%) 753 (77.5%) 3359 (69.5%)
Women 1695 (29.5%) 218 (22.5%) 1477 (30.5%)
Awareness about symptoms of ACS 2286 (40.6%) 413 (44.1%) 1873 (40.0%) 0.01
Mode of transportation 0.0001
108 services 862 (15.4%) 110 (11.7%) 752 (16.1%)
Ambulance 382 (6.8%) 57 (6.0%) 325 (7.0%)
Personal vehicle 2371 (42.3%) 532 (56.4%) 1839 (39.4%)
Public Transportation 450 (8.0%) 39 (4.1%) 411 (8.8%)
Taxi 1395 (24.9%) 167 (17.7%) 1228 (26.3%)
Any other 149 (2.7%) 38 (4.0%) 111 (2.4%)
Median pre-hospital delay (I.Q. range), minutes 780 (242–2358) 450 (139–1486) 849 (280–2532) 0.0001
STEMI 2641 (45.5%) 464 (47.8%) 2177 (45.0%) 0.11 (trend)
NSTEMI 3166 (54.5%) 507 (52.2%) 2659 (55.0%)
CV risk factors
Diagnosed hypertension 2510 (43.4%) 493 (51.0%) 2017 (41.9%) 0.00001
Diagnosed diabetes 1022 (17.7%) 233 (24.1%) 784 (16.4%) 0.0001
Tobacco smokers 3658 (63.4%) 562 (58.2%) 3096 (64.5%) 0.0001
Sedentary 1716 (29.7%) 466 (48.2%) 1250 (25.9%) 0.0001
BMI 4953 (24.0  4.2) 777 (24.3  4.2) 4176 (23.9  4.2) 0.04
Treatment
ASA 5792 (99.8%) 967 (99.8%) 4825 (99.8%) 0.8
Clopidogrel 5792 (98.8%) 967 (99.8%) 4825 (99.8%) 0.8
ACE inhibitors/ARB 4815 (83.7%) 806 (83.8%) 4009 (83.6%) 0.9
B Blockers 4706 (81.1%) 797 (82.08%) 3909 (80.8%) 0.3
Statins 5057 (87.1%) 852 (87.7%) 4205 (86.9%) 0.5
Thrombolytic therapy 939 (16.2%) 230 (23.7%) 709 (14.6%) 0.001
Hypotension 628 (12.6%) 89 (9.9%) 539 (13.2%) 0.01
Cardiogenic shock 455 (10.2%) 69 (8.3%) 386 (10.6%) 0.04
A Fib 5 (0.1%) 1 (0.1%) 4 (0.1%) 0.86
CHB 246 (4.7%) 49 (5.4%) 197 (4.5%) 0.2
VT/VFib. 50 (0.9%) 13 (1.4%) 37 (0.8%) 0.09
Coronary angiography done 83 (1.4%) 20 (2.1%) 63 (1.3%) 0.07
Heparin 4460 (76.8%) 726 (74.8%) 3734 (77.3%) 0.09
VT/VFib. 50 (0.9%) 13 (1.4%) 37 (0.8%) 0.09
Coronary angiography done 83 (1.4%) 20 (2.1%) 63 (1.3%) 0.07
Outcomes
Death 442 (7.6%) 61 (6.3%) 381 (7.9%) 0.08
Bleeding 55 (1.0%) 7 (0.8%) 48 (1.2%) 0.6
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STEMI population receiving thrombolytic therapy was signiﬁ-
cantly higher in urban than in rural STEMI population (49.6%
vs. 32.6%, p < 0.01). Only 37 (0.6%) of ACS population under-
went PCI. 0.9% of STEMI population underwent PCI compared
to 0.4% NSTEMI patients ( p < 0.01). However, tertiary care
center with cath facilities PCI rate was 2.2%. None of the ACS
patient underwent CABG (Tables 2–5).
3.7. Outcomes
In-hospital mortality was 7.6% and was higher in STEMI
patients than in NSTEMI population (10.8% vs. 5.0%, respec-
tively, p < 0.01). The in-hospital mortality was higher among
women and those from rural background. The mortality ratewas signiﬁcantly higher in ACS population admitted in
teaching hospital with catheterization services than in
teaching hospital without cath services, non-teaching hospi-
tals in government, and private sectors; 10.8%, 10.6%, 4.3%, and
5.9%, respectively. 4.7% had CHB and was equally prevalent in
patients admitted across the hospitals types. VT VF was
reported in 0.9% of the population and was similar across the
types of registry centers. 14.8% and 13.4% of the ACS
populations admitted in secondary level hospitals in govt.
and private sectors, respectively, were referred to tertiary care
center due to hemodynamic instability, and/or post-MI angina.
1.0% had major and minor bleeding and was not signiﬁcantly
different among STEMI and NSTEMI patients (1.4% vs. 0.8%, p
0.07). 2.4% had post-MI angina, and there was a trend of higher
prevalence among STEMI than in NSTEMI patients (Tables 2–5).
Table 4 – Clinical characteristics treatment and outcomes in men and women ACS population.
Characteristics Overall Men Women p value
Age 5807 (60.9  12.1) 4112 (59.7  12.0) 1695 (63.7  11.8) 0.0001
STEMI 2641 (45.5%) 2043 (49.7%) 598 (35.3%) 0.001
NSTEMI 3166 (54.5%) 2069 (50.3%) 1097 (64.7%) 0.001
Urban 971 (16.7%) 753 (18.3%) 218 (12.9%) 0.001
Rural 4836 (83.3%) 3359 (81.7%) 1477 (87.1%) 0.001
Pre-hospital delay, median (I.Q. range), minutes 780 (242–2358) 734 (240–2253) 856 (285–2587) 0.001
Hypertension 2510 (43.4%) 1642 (40.1%) 868 (51.4%) 0.001
Diabetes 1022 (17.7%) 644 (15.7%) 378 (22.4%) 0.001
BMI 4953 (24.0  4.2) 3481 (23.9  4.1) 1472 (24.2  4.4) 0.07
Fasting blood glucose (>126), mg/dl 1452 (53%) 980 (53.0%) 472 (55.2%) 0.2
Tobacco consumption 3658 (63.4%) 3296 (80.6%) 362 (21.5%) 0.001
Sedentary 1716 (29.7%) 1217 (29.7%) 499 (29.6%) 0.93
Hemodynamic status
Hypotension 628 (12.6%) 444 (12.5%) 184 (12.8%) 0.7
Cardiogenic shock 455 (10.2%) 328 (10.3%) 127 (9.9%) 0.6
Treatment
ASA 5780 (100%) 4094 (100%) 1686 (100%)
Clopidogrel
B Blockers 4706 (81.1%) 3307 (80.4%) 1399 (82.6%) 0.05
ACE inhibitors/ARB 4716 (82.5%) 3328 (82.3%) 1388 (83.1%) 0.5
Statins 5650 (97.3%) 3992 (97.1%) 1658 (97.9%) 0.07
Thrombolytic therapy 939 (35.6%) 783 (38.3%) 156 (26.1%) 0.01
PCI 37 (0.6%) 29 (0.5%) 8 (0.05%) 0.4
Outcomes
Death 442 (7.6%) 289 (7.0%) 153 (9.0%) 0.01
Bleeding 55 (1.0%) 42 (1.1%) 13 (0.8%) 0.5
Post-MI angina 125 (2.4%) 106 (2.8%) 19 (1.2%) 0.001
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) 1 1 8 – 1 2 71243.8. Predictors of in-hospital deaths
Multi-variable stepwise regression modeling was done to
determine the independent predictors of in-hospital death.
Age, diabetes, STEMI, and Killip class 111/1V were strong
independent predictors of increased in-hospital deaths. Pre-
hospital delay adjusted for other predictors was not found to
have independent predictive value for increased in-hospital
mortality. Literacy status and increasing BMI had lower in-
hospital mortality. Gender and geographical characteristics
had no signiﬁcant association with in-hospital mortality
(Table 6).
4. Discussion
We analyzed data from large HP ACS Registry in the state of HP
covering more than 90% of the state population.
4.1. Summary of HP ACS Registry ﬁndings
ACS population in hill state of HP is characterized by: mean age
of 60 years, NSTEMI is more common than STEMI, mean age is
higher than STMI and is more frequent in women. About 83%
of ACS population was from rural area. NSTEMI patients were
more often associated with hypertension, diabetes and
obesity, while STEMI patients were associated with tobacco
consumption. Median pre-hospital delay was 780 min and
signiﬁcantly longer for rural ACS population than urban
population. Only one-third of the patients reported within
6 h of symptom onset. Lack of awareness of symptoms of ACS,consulting local practitioners, and long traveling time were the
main reasons for inordinately longer pre-hospital delay. One-
third of the ACS population were admitted in teaching hospital
with catheterization facilities, while only about 10% were
treated in private secondary care hospitals. About 10% of the
ACS population were hemodynamically unstable and were
more frequent in STEMI than in NSTEMI. Only 35.6% received
thrombolytic therapy and 0.6% underwent PCI. All patients
received Antiplatelets; Statins were prescribed in more than
97%, whereas B Blockers and ACE inhibitors/ARB were
prescribed in more than 80%. In-hospital mortality was 7.6%
and was signiﬁcantly high in STEMI than NSTEMI (10.8% vs.
5.0%, p < 0.001).
4.2. Comparison with prior ACS Registry
Proportion of ACS population with NSTEMI was more
common than STEMI unlike reported in CREATE12 and
OASIS10 Registry from India, however, is similar to reports
of Kerala ACS Registry.13 The mean age of the ACS population
is higher compared to CREATE Registry12 but is similar to
Kerala Registry.13 However, the mean age of the STEMI was
lower than NSTEMI unlike Kerala ACS Registry,13 where there
was no difference in mean age of STEMI and NSTEMI
patients. It is intriguing that the characteristics of the ACS
population change with transition in sociodemographic
characteristics of the general population. With improvement
in socioeconomic status of the population, the age of
incidence of ACS increases, NSTEMI becomes more frequent,
and the difference in the mean age of men and women ACS
population narrows. In this context, the characteristics of
Table 5 – Clinical characteristics, treatment, and outcomes in ACS population registered across types of hospitals.
Characteristics Overall Teaching
hospitals
with
catheterization
facilities (IGMC)
Teaching
hospital
without
catheterization
facilities
Secondary
level
institutions
in Govt.
sector
Secondary
level hospitals
in private
sector
p value
Age 60.9  12.1 59.5  12.2 59.5  12.2 613  11.9 62.0  12.2 0.001
Sex (men) 4112 (70.8%) 1290 (75.8%) 782 (67.5%) 1666 (68.7%) 374 (71.4%) 0.001
Education level, median
(I.Q. range)
8 (0–10) 8 (0–10) 8 (0–10) 6 (0–10) 8 (0–10) 0.01
Urban 971 (16.7%) 446 (26.2%) 52 (4.5%) 413 (17.0%) 60 (11.5%) 0.001
Rural 4836 (83.3%) 1255 (73.8%) 1106 (95.5%) 2011 (83.0%) 464 (88.5%)
Pre-hospital delay, median
(I.Q. range), minutes
780 (242–2358) 970 (330–2784) 630 (265–1920) 544 (195–1710) 795 (183–2655) 0.0001
Proportion of ACS reporting
within 6 h
1915 (33.0%) 366 (21.5%) 405 (35.0%) 952 (39.5%) 192 (36.6%) 0.001
CV risk factors
Hypertension 2510 (43.4%) 635 (37.4%) 502 (43.4%) 1104 (45.7%) 269 (52.3%) 0.001
Diabetes 1022 (17.7%) 304 (17.9%) 248 (21.4%) 386 (16.0%) 84 (16.4%) 0.01
Tobacco Smoker 3658 (63.4%) 1189 (70.0%) 733 (63.4%) 1451 (60.5%) 285 (52.2%) 0.001
Sedentary 1716 (29.7%) 675 (39.7%) 181 (15.6%) 698 (29.0%) 162 (31.5%) 0.0001
BMI 4953 (24.0  4.2) 1200 (22.2  3.4) 1119 (23.6  4.1) 2166 (25.2  4.3) 468 (23.9  4.2) 0.001
STEMI 2641 (45.5%) 882 (51.9%) 487 (42.1%) 1025 (42.3%) 247 (48.1%) 0.001
NSTEMI 3166 (54.5%) 819 (48.1%) 671 (57.9%) 1399 (57.7%) 277 (52.9%) 0.01
Cardiogenic shock 455 (10.2%) 164 (11.2%) 111 (14.3%) 143 (7.7%) 37 (10.0%) 0.001
Hypertensive 628 (12.6%) 220 (13.4% 164 (17.8%) 204 (10.1%) 40 (9.6%) 0.001
CHB 246 (4.7%) 91 (6.0%) 43 (4.2%) 89 (3.9%) 23 (4.8%) 0.02
VT/VF 50 (0.9%) 12 (0.8%) 12 (1.2%) 17 (0.8%) 9 (1.9%) 0.08
Treatment
ASA 5780 (100%) 1695 (100%) 1158 (100%) 2405 (100%) 522 (100%)
Clopidogrel 5789 (100%) 1696 (100%) 1158 (100%) 2412 (100%) 523 (100%)
B Blockers 4706 (81.1% 1297 (76.3%) 923 (79.7%) 2059 (84.9%) 427 (81.6%) 0.001
ACE inhibitors/ARB 4716 (82.5%) 1394 (83.5%) 877 (77.0%) 2013 (86.3%) 382 (74.3%) 0.0001
Statins 5650 (97.3%) 1664 (97.9%) 1150 (99.3%) 2364 (97.5%) 472 (90.2%) 0.001
Proportion of STEMI
received thrombolytic
therapy
939 (35.6%) 286 (32.5%) 207 (42.5%) 322 (31.4%) 124 (50.2%) 0.001
PCI 37 (0.6%) 37 (2.2%) Nil Nil Nil
Outcomes
Death 442 (7.6%) 184 (10.8%) 123 (10.6%) 104 (4.3%) 31 (5.9%) 0.0001
Bleeding 55 (1.0%) 10 (0.7%) 15 (1.5%) 25 (1.1%) 5 (1.0%) 0.02
Post-MI angina 125 (2.4%) 42 (2.8%) 5 (0.5%) 65 (2.9%) 13 (2.7%) 0.03
Hospital stay, Median
(I.Q. range) days
4 (3–6) 5 (3–7) 4 (2–5) 5 (3–6) 5 (2–6) 0.001
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state,13 while other regions of the country reﬂected by
CREATE Registry12 appear to be in trailing stage of epidemi-
ological transition of ACS.Table 6 – Multivariable logistic regression modeling of
independent predictors of in-hospital deaths.
Outcome status Odds
ratio
p value [95% Conf.
Interval]
Age 1.02646 0.000 1.014685–1.038371
Gender 0.8337839 0.223 0.6224593–1.116853
Urban 0.9490128 0.795 0.6393988–1.40855
Literates 0.6769331 0.010 0.5028687–0.9112487
Diabetics 1.863109 0.000 1.3989–2.481358
STEMI ACS 1.941678 0.000 1.495607–2.52079
BMI 0.9616202 0.016 0.9315808–0.9926283
Killip class 111/1V 8.007989 0.000 6.144254–10.43705
Pre-hospital delay 1.049987 0.310 0.9555333–1.153777The use of reperfusion therapy was signiﬁcantly low in HP
ACS Registry than reported in previous registries from India
and other developed countries.3–10,12,13 This is because of the
fact that pre-hospital delay was signiﬁcantly high. The median
delay of 780 min was greater compared to 300 min in CREATE
Registry12 and was much lower reported from developed and
other developing countries.3–10,12,13 Only about 30% reported
within 6 h of symptom onset. The thrombolysis rate also
varied signiﬁcantly across the types of hospitals. Thrombolytic
rate was highest in private hospitals (50%), while it was least in
secondary care hospitals in government sector (31.4%).
Although pre-hospital delay was least in secondary care
hospitals in government sector (median delay of 544 min), the
thrombolytic therapy rate was least in the secondary care
hospitals. The low rate of thrombolysis in secondary care
hospitals in govt. sectors may be due to limited number of
physicians posted; thus, they are not available on all days for
providing care to ACS patients. The general duty medical
ofﬁcers are not competent to take decision for thrombolytic
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) 1 1 8 – 1 2 7126therapy. Thus, this brings out an important gap in the health
care system in government sector that needs to be addressed.
The lower rates of thrombolysis in teaching hospital have
been primarily due to long pre-hospital delay and thus
reporting out of window period. The negligible rate of PCI in
HP ACS Registry is due to the fact that only one center in
whole of state has the catheterization facilities, and this too
only provides PCI services during working hours. The other
reason of lower PCI rate of 2.2% in center with PCI facilities is
the affordability. Most of the patients pay the cost out of
pocket. The use of other evidence-based medicine for
secondary prevention: Antiplatelets, Statins, ACE inhibitors,
and B Blockers are much higher than reported from previous
registries from India and other registries from developed
countries.3–10,12,13 This reﬂects the fact that physicians in the
state are well informed about the use of evidence-based
medicines. There is a need for further improving the use of
ACE inhibitors and B Blockers in high-risk patients, as the use
is less frequent in STEMI than in NSTEMI patients. The in-
hospital mortality was 7.6% that is higher than in-hospital
mortality reported in CREATE12 registry of 5.6% and Kerala
ACS Registry.13 The high mortality rate in HP ACS Registry is
due to long pre-hospital delay, and lower reperfusion rate;
thus, has an implication for making informed interventions
to reduce pre-hospital delay and to improve reperfusion
therapy. Adjusted analysis of predictors of in-hospital
mortality revealed that age, diabetic status, patients with
unstable hemodynamic; Killip class 111/1V, and STEMI ACS
population as expected carried worse prognosis. However
interestingly, increasing BMI and literacy status were
associated with lower mortality. The possible reasons for
lower mortality among literate population could be higher
thrombolysis rate in literate population than in illiterate ACS
group (75.8% vs. 24.2%, p < 0.001). Gender, geographical
characteristics, and pre-hospital delay were not signiﬁcantly
associated with in-hospital mortality when adjusted for
other variables.
Tobacco consumption is the most frequent risk factor
prevalent both in rural and urban population, while hyperten-
sion, diabetes, obesity and sedentary lifestyle are the major
drivers of ACS in urban population. Thus, appropriate health
system responses directed toward effective implementation of
evidence-based public health intervention, primary and
secondary preventive measures are required to reduce the
incidence of ACS and its related morbidity and mortality.
4.3. Limitations of the study
The ACS cases recorded in some of the centers may not have
been consecutive, especially during the time when the
physician at the site is on leave and out of station for some
assignments, and patients who died in the casualty before
shifting to CCU, and wards in some of the centers may not
have been registered, thus the data may not be true
representative. The data related to some of the clinical
characteristics were missing in some patients, as it could
not be corrected due to late uploading of data due to internet
connectivity issues. Post-discharge follow-up data are not
captured to evaluate the adherence to secondary preventive
interventions, and major adverse cardiovascular events.4.4. Strength
The registry centers included all the hospitals in teaching and
non-teaching secondary care hospitals in government sector
except two out of 12 districts. Out of 10 private hospitals
treating patients of ACS, 5 volunteered to participate. Overall,
more than 80% of the ACS population is treated in government
sector in HP. Thus, HP ACS Registry data cover more than 90%
of the ACS population and is thus representative data of the
state reﬂected by rural urban ACS population distribution
mirroring the normal rural urban population distribution.
4.5. Implications for quality improvement
The pre-hospital delay and low rate of thrombolysis are two
important barriers and gaps in the health care system. The
quality improvement strategies are being recommended to be
implemented by the state health department through com-
munity education program to improve the awareness about
ACS symptoms and inﬂuence the health seeking behaviors
and educating community about the health care centers to be
visited in event of ACS. Some of the quality initiatives could be
identifying strategically located high volume primary health
care centers and strengthening with tele ECG equipments to
provide decision support system by linking with physicians
and cardiologists to guide institution of time sensitive
treatment before referral to secondary or tertiary care centers.
Tele ECG machines are installed in 60 PHC/CHC's and civil and
district hospitals. The capacity building exercises across all
level of health care centers in the state are planned in near
future, and its impact would be recorded and would be
reported in subsequent report.
4.6. Conclusions
The ACS population in the hill state of HP is characterized by
higher mean age, more frequent NSTEMI, equally prevalent in
urban and rural population, STEMI more common in men and
NSTEMI being more frequent in women. STEMI patients are
younger, more often smoker and more frequent in men, while
NSTEMI are older, more often associated with hypertension,
diabetes, obesity and more frequent in women. Pre-hospital
delay is inordinately higher than reported from other parts of
the country. The reperfusion therapy received was signiﬁ-
cantly low and in-hospital mortality was higher than reported
in other registries in India. Use of Antiplatelets, Statins, B
Blockers, and ACE inhibitors/ARB's were highest than reported
in other registries. These observations have important
implications in improving the scope of treatment and out-
comes through intervention at health system level.
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